Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC
Chi-Heng Wu(National Taiwan University), Weiyun Z. Ai(City College of San Francisco), Ryan M. Gill(University of California, San Francisco), James L. Rubenstein(UCSF Helen Diller Family Comprehensive Cancer Center), Taha Rakhshandehroo(University of California, San Francisco), Hua-Xin Gao(University of California, San Francisco), Ronald Balassanian, Frank McCormick(Frederick National Laboratory for Cancer Research), Laura B. Pincus(University of California, San Francisco), Linlin Wang(University of California, San Francisco), Sourav Bandyopadhyay(University of California, San Francisco), Mark M. Moasser(University of California, San Francisco), Chen‐Yen Yang(University of California, San Francisco), Shervin Afghani(University of California, Berkeley)
Cited by 21
Related Papers
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k